Professional Documents
Culture Documents
Pharmacist suspended
EpiPen auto-injector recall
They
The registration of a Tasmanian
pharmacist was suspended for Alphapharm, in adrenaline in a
swiped
six weeks earlier this year, after consultation with the timely manner or
he admitted to professional Therapeutic Goods may not even get
misconduct in relation to
inappropriate supply of scheduled
Administration (TGA),
has announced
any adrenaline at
all, with potential your
medications and inadequate record
keeping.
it is recalling four
batches of EpiPen 300
life-threatening
consequences such
pen
The Pharmacy Board of Australia
referred Michael Meaney to the
microgram adrenaline
injection syringe auto-injectors, due reactions.
as anaphylactic again?
Health Practitioners Tribunal to the potential failure to activate The TGA was very specific about
Join a pharmacy
of Tasmania for allegedly or the need to apply increased no other batches of EpiPen,
inappropriately supplying S8, S4 force to activate the device. including EpiPen Jr 150 microgram group that keeps
and S4D medications on numerous Pharmacies are to be the point adrenaline injection syringe an eye on your
occasions, inadequate record of return for a refund or exchange auto-injectors, being affected by inventory so you
keeping, inappropriately saving from a different, unaffected batch this issue and were therefore not
previously dispensed and returned free of charge, the TGA said. subject to this recall. can keep an eye
medications, and resupplying as EpiPens from the four affected Any questions or concerns around on better service
unused medications those that batches have been said to contain this issue should be addressed to
were previously dispensed and a defective part that could result in Alphapharm on 1800 274 276.
returned to the pharmacy. the auto-injector failing to activate
Meaney was working as the sole or a need to apply more force than AND FOCUS ON
pharmacist at a rural Tasmanian normal to activate. New pathway consult WHATS IMPORTANT
pharmacy at the time the alleged The affected batch numbers, The TGA is inviting submissions
incidents occurred in 2013. all with an Apr 2017 expiry, are on a new Provisional Approval YOUR CUSTOMER
The offences included supplying 5FA665, 5FA6651, 5FA6652 and pathway for prescription medicines,
emergency medication outside of 5FA6653. which will allow sponsors to
the Poisons Regulations, and the The TGA said there had been two seek a time-limited provisional
supply of medication to several confirmed reports of auto-injectors registration of drugs that do not
interstate customers without a valid from these batches failing to meet full clinical data requirements.
prescription. activate correctly world-wide from The pathway is intended for use
The tribunal accepted the admitted around 80,000 devices distributed. where the potential benefits of
conduct was well intended, but If this were to happen, there is earlier availability outweighs risks, CLICK HERE
amounted to a misguided approach a risk that the patient may not with input required by 01 May. to.meet.the.family
to the practice of pharmacy. receive the appropriate dose of See www.tga.gov.au.
BOOKKEEPING, PAYROLL,
ONLINE DOCUMENT MANAGEMENT
Only a pharmacist can truly understand
your business
Click here for more info or call 1800 961 962
The original
No.1
probiotic PLUS
Always read the label. Use only as directed.
Pharmacy Daily Tuesday 21st March 2017 t 1300 799 220 w www.pharmacydaily.com.au page 1
Do you have the Pharmacy
Daily app?
Pharmacy Daily is Australias favourite pharmacy industry publication. Publisher/Editor in chief: Bruce Piper Editorial: info@pharmacydaily.com.au
Sign up free at www.pharmacydaily.com.au. Managing Editor: Jon Murrie
Postal address: PO Box 1010, Epping, NSW 1710 Australia Reporter: Mal Smith
Street address: Level 2, Suite 1 64 Talavera Rd, Macquarie Park NSW 2113 Australia Contributors: Matt Bell, Rebecca Le Bas, Jasmine ODonoghue
Advertising and Marketing: Sean Harrigan and Melanie Tchakmadjian advertising@pharmacydaily.com.au
P: 1300 799 220 (+61 2 8007 6760) F: 1300 799 221 (+61 2 8007 6769)
Business Manager: Jenny Piper accounts@pharmacydaily.com.au
Part of the Business Publishing Group.
business events news
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of
the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Pharmacy Daily Tuesday 21st March 2017 t 1300 799 220 w www.pharmacydaily.com.au page 2